Quest Diagnostics Incorporated (NYSE:DGX) agreed to acquire Select Laboratory Assets of Allina Health from Allina Health System, Inc. on June 26, 2024. The deal is subject to regulatory approval. The transaction is expected to close in the third quarter of 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
144.1 USD | +0.43% |
|
+2.61% | +4.52% |
Jul. 10 | Quest Diagnostics to Buy OhioHealth's Outreach Lab Services Business | MT |
Jul. 10 | Citigroup Upgrades Quest Diagnostics to Buy From Neutral, Adjusts Price Target to $165 From $145 | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.52% | 16.01B | |
+19.84% | 84.94B | |
-25.24% | 74.07B | |
-1.34% | 26.15B | |
+4.56% | 18.03B | |
-9.29% | 17.38B | |
+78.16% | 13.7B | |
+77.84% | 13.13B | |
-26.14% | 12.74B | |
+20.99% | 12.34B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Quest Diagnostics Incorporated agreed to acquire Select Laboratory Assets of Allina Health from Allina Health System, Inc.